ALSP Inc. Advisors
Vivian Hook, Ph.D.
Scientific Founder and Chief Scientific Advisor of American Life Science Pharmaceuticals and Professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences, at the University of California, San Diego
Professor Hook has over 20 years experience in the field of neuroprotease research and is the author of over 160 scientific articles and books on that subject. Dr. Hook previously was a Professor at the Buck Institute for Aging Research, Novato, California, Professor of Medicine and Neuroscience at the University of California, San Diego and a Professor at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. She was trained as a molecular pharmacologist and did post-doctoral studies at the National Institute of Health, Bethesda, Maryland, with Dr. Julius Axelrod, a Nobel Prize winner for his research in neuroscience. She holds a Ph.D. in Pharmacology from the University of California, San Francisco and a BA in Medical Physics from the University of California Berkeley.
Michael Grundman, M.D. M.Ph, Acting CMO
Acting Chief Medical Officer, ALSP, Inc.
Michael Grundman, M.D. M.Ph, is President and CEO of Global R&D Partners, LLC, a pharmaceutical consulting firm based in San Diego, California. The mission of Global R&D Partners, LLC is to help pharmaceutical and biotechnology companies develop novel agents for the diagnosis and treatment of serious and life threatening diseases.
Dr. Grundman previously served as Vice President of Clinical Development at Janssen Alzheimer Immunotherapy, LLC and as Vice President of Clinical Development at Elan Pharmaceuticals, Inc. Prior to joining industry Dr. Grundman was Associate Director of the Alzheimer's Disease Cooperative Study (ADCS) at the University of California, San Diego (UCSD) and is currently an Adjunct Professor of Neurosciences at UCSD. Dr. Grundman received his BA from New York University magna cum laude with Honors in Biochemistry. He obtained his MD and Neurology training at the Albert Einstein College of Medicine and a Master of Public Health degree from Columbia University. Dr. Grundman previously served on the FDA Peripheral and Central Nervous System Advisory Committee and is an inventor on a number of patents related to Alzheimer's disease therapy. Dr. Grundman has lectured at numerous national and international scientific meetings and has published over 60 articles related to Alzheimer's disease and dementia.
Joyce Williams, MBA, RAC
Regulatory Affairs Consultant
Ms. Williams is President and Principal Consultant at ProFocus Regulatory Solutions in La Jolla, CA. She provides regulatory and development consulting services for pharmaceutical, biotech and device companies . She has been involved in the regulatory strategy ALSP's compounds since the first compound entered development.
Prior to establishing her consulting business, Ms. Williams held the positions of VP, Regulatory Affairs (RA) at Arena Pharmaceuticals; Executive Director of RA for Johnson and Johnson; VP Regulatory and Clinical Affairs at Telios Pharmaceuticals; VP RA at Monsanto Corp. She has been responsible for the successful submission of one approved 510K, four approved NDAs and one approved ANDA.
< Back
